Dr Reddy’s Laboratories has secured European Commission approval for AVT03, its biosimilar of Prolia and Xgeva used in treating osteoporosis and bone-related conditions. Developed by Alvotech, the product will be commercialised by Dr Reddy’s across the US, Europe, and other market
